Mark G Alexandrow

54PUBLICATIONS

262CO-AUTHORS

Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Oral and maxillofacial surgeryPacific Peoples youth and family

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (54)

Sort by Publication Date:

|May 14, 2026

PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

|May 04, 2026

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

|Apr 23, 2026

Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?

|Mar 16, 2026

Osteosarcoma is not a single disease: Considerations for multidisciplinary management of jaw (gnathic) osteosarcoma.

Damon R Reed, Emily K Slotkin

|Feb 12, 2026

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Dec 01, 2025

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar

Pageof 9

Frequent Collaborators

Katherine A Janeway

Richard Gorlick

Steven G DuBois

Brian D Crompton

Patrick J Grohar

Emily Slotkin

Kelly M Bailey

Viswatej Avutu

Leo Mascarenhas

William Tap

Frequent Collaborators

Katherine A Janeway

Richard Gorlick

Steven G DuBois

Brian D Crompton